{"id":54762,"date":"2023-03-13T14:06:37","date_gmt":"2023-03-13T13:06:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/"},"modified":"2023-03-13T14:06:37","modified_gmt":"2023-03-13T13:06:37","slug":"roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/","title":{"rendered":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team"},"content":{"rendered":"
\n

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ROTH MKM (\u201cRoth\u201d), www.roth.com<\/a>, a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm\u2019s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap Biotechnology companies across the therapeutic space, with an initial focus on companies developing novel drugs for immunology, inflammatory diseases, metabolic diseases, and oncology.\n<\/p>\n

<\/a><\/p>\n

\nPrior to joining ROTH MKM, Dr. Dupuis was a SMID-cap Biotech Analyst at Altium Capital, a healthcare-focused hedge fund. Prior to Altium, he spent two years at SVB Leerink as VP – Equity Research, Senior Associate. Prior to SVB Leerink, he was a Research Associate at B. Riley FBR. Dr. Dupuis received his Ph.D. in Molecular Biology from Lehigh University focused on A-to-I RNA editing and completed a Post-Doctoral Research Fellowship at the Center for Vascular Biology Research at Beth Israel Deaconess Medical Center, Harvard Medical School. He received his B.S. in Biology and Chemistry from Lycoming College.\n<\/p>\n

\nJeff Martin, CFA \u2013 Co-Director of Research, commented, \u201cROTH MKM continues to invest in biotechnology research talent to enhance the strength of our Healthcare platform. I\u2019m pleased to welcome Dylan to our thought-leading biotechnology research team. His strong academic background combined with his experience covering innovative and underappreciated biotechnology companies will undoubtedly serve our clients well.\u201d\n<\/p>\n

\nDr. Dupuis commented, \u201cI am thrilled to be joining ROTH MKM, which holds a strong history in healthcare. I look forward to contributing to its legacy of providing high-quality, in-depth, fundamental research. My goal is to focus on innovative technology grounded by excellent science that aims to address unmet medical needs, while providing favorable risk-reward for investors.\u201d\n<\/p>\n

\n\u201cWe are excited to have Dylan join our healthcare research team,\u201d said Sagar Sheth, CEO of ROTH MKM. \u201cHis diverse experience in a variety of therapeutic areas is an excellent fit for our biotechnology research platform. I\u2019m confident that Dylan\u2019s expertise in biotechnology will provide valuable insights for clients and help build upon our long track record in the healthcare sector.\u201d\n<\/p>\n

\nSince 2010, ROTH MKM has been involved in approximately 570 transactions for its Healthcare clients, with total transaction value over $25 billion. (Source: ROTH MKM | 3\/10\/23)\n<\/p>\n

\nAbout ROTH MKM<\/b>\n<\/p>\n

\nROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Our full service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately-held, employee owned organization and maintains offices throughout the U.S. For more information, please visit www.roth.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor and Media Contact: <\/b>ROTH MKM, Isabel Mattson-Pain, Director of Marketing, Imattson-pain@roth.com<\/a>, 949-720-7117.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ROTH MKM (\u201cRoth\u201d), www.roth.com, a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm\u2019s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap Biotechnology companies across the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54762","6":"format-standard","7":"category-industry"},"yoast_head":"\nROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ROTH MKM (\u201cRoth\u201d), www.roth.com, a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm\u2019s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap Biotechnology companies across the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-13T13:06:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team\",\"datePublished\":\"2023-03-13T13:06:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/\"},\"wordCount\":482,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005164\\\/en\\\/1735943\\\/21\\\/MKMROTH_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/\",\"name\":\"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005164\\\/en\\\/1735943\\\/21\\\/MKMROTH_Logo.jpg\",\"datePublished\":\"2023-03-13T13:06:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005164\\\/en\\\/1735943\\\/21\\\/MKMROTH_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005164\\\/en\\\/1735943\\\/21\\\/MKMROTH_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/","og_locale":"en_US","og_type":"article","og_title":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend","og_description":"NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ROTH MKM (\u201cRoth\u201d), www.roth.com, a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm\u2019s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap Biotechnology companies across the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-13T13:06:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team","datePublished":"2023-03-13T13:06:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/"},"wordCount":482,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/","url":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/","name":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg","datePublished":"2023-03-13T13:06:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230313005164\/en\/1735943\/21\/MKMROTH_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/roth-mkm-announces-the-addition-of-dylan-dupuis-ph-d-to-its-healthcare-research-team\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54762"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54762\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}